Member Info for Henners007

Uncle Doug - real value here. We are being offered +/- 21.5p per share at the end of June for c14.5% of our shareholdings. That's an uplift of over 35% in 6 weeks.

I benefitted from the last tender offer in 2025. Plus (providing you can buy into the underlying fundamentals of what Schroders are doing), there is the reasonable expectation of further good news over the next two/three/four/five years until the company is wound up. They have a reasonable chunk of the portfolio in Revolut - enough said.

Agree. A bird in the hand………..and all that

Excellent timing. Revolut is a private company. INOV is an intelligent way to have an interest in Revolut at >30% discount to NAV

You do not spend time, effort, sweat and money on getting placebo's patented around the globe.

Tim tactics - As we know, this investment fund is something of an anomaly. It presently trades about 35% below NAV. The Manager's confidence in the underlying assets encouraged them to pay out to willing shareholders at NAV during the middle of this year. That shows great confidence in the underlying valuations.

I am going to hold until the end. Last man standing and all that. It is quite possible (probable?!), that the ultimate sp might be considerably higher than where it is today. The Revolut listing pending is one example.

We all know about stockmarket vagaries, but it feels that relative to other investments, INOV could just deliver a very attractive return from hereon in..................and the l;ast 12 months return hasnt been too shabby either.

IOF's record of constructing and bringing to production its recent Iosorb plants has been exemplary. And all financed from own resources. The share price dial has got to start ticking up soon. This new plant and significant partner is a step change for the company if execution is carried out as planned.

Agree Brondby. Once all these shares rank pari passu with the existing shares, share price will drop much closer to the 1p level. Unfortunately many shareholders don't appreciate they need to double/triple/quadruple down on their investment now just to stand still. Depends of course what price was paid for initial shareholding, but those that bought above the 15p level should, logically either sell out entirely or will need to top up considerably at this juncture.

FWIW I still believe there is some value in the forthcoming gels, but reputation so badly tarnished it might not matter.

Ain’t no way we will break 30p in 12 months.

Massive money raise incoming. Extra shares in issue at very low share price, most shareholders will be out of the money for ever, unless you heavily subscribe for new shares.

I have retained a tiny stake to watch how this unfolds. The money raise is going to be very painful indeed. 1p/1.5p/2p who knows.

Sharp upward revaluation of Revolut may well give the Board of INOV food for thought. A bird in the hand and all that..............................

Given that INOV is in wind down mode, and Revolut was 2nd largest shareholding perhaps they will consider reducing/selling down their shareholding.

We are due a new quarterly valuation shortly methinks.

Economics is not that "simple". If your cost of production is £12 and your sale price is £10. Better to sell 10 at £25.

40p won't be the take out price. The analysts valuation was over 100p WITHOUT Eroxxon intense and the girlie version.

Over 100 trades in the first 30 minutes of trading. I don't recognise this Company any more...............................!!!

The female version (which has no competitors) will add real value. LO insisting on change at the top indicates they are fast tracking their exit strategy.

The next 12 months could be even more exciting than the last 12 months (and for the right reasons this time).

Absolutely correct.

Eroxxon is most definitely available to buy and be delivered off amazon. I have just bought two packs and can deliver to The Lord if he provides his safe address.

Understand your logic Dartron. It's never wrong to take a profit. However, within the next fortnight we should hear about the tender offer the Company is to put before shareholders. This is highly likely to be above the prevailing share price.

Appreciated cheeseburger. I shall review.

Appreciated cheeseburger. I shall review.

What is their strategy?

Look where the sp is now.......................................why?